Clinical Trials and Cohort Studies Grants support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health.
The desired outcomes of the Clinical Trials and Cohort Studies Grants opportunity are improvements in health and well-being, health care practice or policy, as a result of:
- high-quality clinical trials that provide reliable evidence of the effects of health-related interventions on health outcomes (or appropriate surrogates), and/or
- high-quality cohort studies that provide reliable evidence on the relation of important risk factors and other exposures to health-related outcomes.
Level of funding
The amount of funding for a Clinical Trials and Cohort Studies Grant will be based on assessment of the requested budget. Refer to the Grant Guidelines available on GrantConnect.
Clinical Trials and Cohort Studies Grants may be funded by or in conjunction with other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations.
For the Clinical Trials and Cohort Studies Grants 2019 opportunity, the funding partner/s include:
- Cancer Australia & Funding Partners.
Peer Review of Clinical Trials and Cohort Studies Grants
Applications to the Clinical Trials and Cohort Studies (CTCS) Grants 2019 opportunity will be assessed in accordance with the assessment criteria set out in the Grant Guidelines (available on GrantConnect). The category descriptors are also provided within the Grant Guidelines.
The CTCS 2019 Peer Review Guidelines is available in the 'Downloads' section below.
If you need more information contact your Research Administration Office (RAO) in the first instance. If you are unable to satisfy your concern through your RAO, contact the Research Help Centre on 1800 500 983, or email firstname.lastname@example.org